# Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.

> **NCT00720616** · NA · WITHDRAWN · sponsor: **Oregon Health and Science University**

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Norditropin

## Key facts

- **NCT ID:** NCT00720616
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720616, "Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00720616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*